PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations. [electronic resource]
Producer: 20061205Description: 692-7 p. digitalISSN:- 0090-8258
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Endometrioid -- drug therapy
- Female
- Genes, BRCA1
- Genes, p53
- Genes, ras
- Humans
- Immunohistochemistry
- Loss of Heterozygosity
- Mutation
- Organoplatinum Compounds -- administration & dosage
- Ovarian Neoplasms -- drug therapy
- PTEN Phosphohydrolase -- biosynthesis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.